|
Post by peppy on Oct 2, 2017 7:31:56 GMT -5
|
|
|
Post by dejude42 on Oct 2, 2017 7:36:29 GMT -5
peppy Thank You for info. I was having a hard time finding link. GLTAL
|
|
|
Post by celo on Oct 2, 2017 7:55:24 GMT -5
Are we doing the little quick comment section during the CC?
|
|
|
Post by mnkdfann on Oct 2, 2017 7:58:00 GMT -5
I wonder if I'm the only one who signs in for access as 'Olivier Brandicourt'.
|
|
|
Post by patten1962 on Oct 2, 2017 9:01:22 GMT -5
I missed the call. What was said?
|
|
|
Post by peppy on Oct 2, 2017 9:28:19 GMT -5
I missed the call. What was said? hello patten. you can listen to the call later. what was said. table four allows Mannkind to differentiate afrezza from other insulins. money has been raised.
www.screencast.com/t/PRuoaiIP look at the table. subq rapid acting insulin last 5 hours.... the tail.
with afrezza, it seems less death becomes us.
New contract with large insurer expected 2018.
|
|
|
Post by minnlearner on Oct 2, 2017 9:38:33 GMT -5
Peppy: As usual, you are truly appreciated for your insights. Thank you for all you help!! {you , ALSO, Rancho} (:
|
|
|
Post by patten1962 on Oct 2, 2017 10:08:38 GMT -5
I missed the call. What was said? hello patten. you can listen to the call later. what was said. table four allows Mannkind to differentiate afrezza from other insulins. money has been raised.
www.screencast.com/t/PRuoaiIP look at the table. subq rapid acting insulin last 5 hours.... the tail.
with afrezza, it seems less death becomes us.
New contract with large insurer expected 2018.
Ty, I have been trying but it is not available yet. Thank you.
|
|
|
Post by dreamboatcruise on Oct 2, 2017 10:23:36 GMT -5
I missed the call. What was said? hello patten. you can listen to the call later. what was said. table four allows Mannkind to differentiate afrezza from other insulins. money has been raised.
www.screencast.com/t/PRuoaiIP look at the table. subq rapid acting insulin last 5 hours.... the tail.
with afrezza, it seems less death becomes us.
New contract with large insurer expected 2018.
I did not hear the call. What was the news on money raised?
|
|
|
Post by peppy on Oct 2, 2017 10:42:04 GMT -5
hello patten. you can listen to the call later. what was said. table four allows Mannkind to differentiate afrezza from other insulins. money has been raised.
www.screencast.com/t/PRuoaiIP look at the table. subq rapid acting insulin last 5 hours.... the tail.
with afrezza, it seems less death becomes us.
New contract with large insurer expected 2018.
I did not hear the call. What was the news on money raised? investors.mannkindcorp.com/events.cfm
mnkd.proboards.com/thread/8703/form-8
Item 1.01 Entry into a Material Definitive Agreement.
Warrant Exchange Agreements
On September 29, 2017, MannKind Corporation (the “Company”) and the four holders of all outstanding Series A Common Stock Purchase Warrants and Series B Common Stock Purchase Warrants of the Company (collectively, the “Warrants”) entered into separate, privately-negotiated exchange agreements (the “Exchange Agreements”), pursuant to which the Company agreed to issue to such holders an aggregate of 1,292,508 shares of the Company’s common stock (the “Exchange Shares”) in exchange for the Warrants. The closings of the exchanges contemplated by the Exchange Agreements are expected to occur on October 3, 2017, subject to the satisfaction of certain closing conditions.
The foregoing description of the Exchange Agreements is qualified in its entirety by reference to the form of Exchange Agreement, a copy of which is attached as Exhibit 99.1 to this report.
Item 3.02 Unregistered Sales of Equity Securities.
The information set forth under Item 1.01 of this report is incorporated by reference into this Item 3.02. The Company offered the Exchange Shares in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended.
This report does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful.
|
|
|
Post by therealisaching on Oct 2, 2017 10:53:54 GMT -5
I did not hear the call. What was the news on money raised? investors.mannkindcorp.com/events.cfm
mnkd.proboards.com/thread/8703/form-8
Item 1.01 Entry into a Material Definitive Agreement.
Warrant Exchange Agreements
On September 29, 2017, MannKind Corporation (the “Company”) and the four holders of all outstanding Series A Common Stock Purchase Warrants and Series B Common Stock Purchase Warrants of the Company (collectively, the “Warrants”) entered into separate, privately-negotiated exchange agreements (the “Exchange Agreements”), pursuant to which the Company agreed to issue to such holders an aggregate of 1,292,508 shares of the Company’s common stock (the “Exchange Shares”) in exchange for the Warrants. The closings of the exchanges contemplated by the Exchange Agreements are expected to occur on October 3, 2017, subject to the satisfaction of certain closing conditions.
The foregoing description of the Exchange Agreements is qualified in its entirety by reference to the form of Exchange Agreement, a copy of which is attached as Exhibit 99.1 to this report.
Item 3.02 Unregistered Sales of Equity Securities.
The information set forth under Item 1.01 of this report is incorporated by reference into this Item 3.02. The Company offered the Exchange Shares in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act of 1933, as amended.
This report does not constitute an offer to sell, or a solicitation of an offer to buy, any security and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offering would be unlawful.
There was no money raised. There was an exchange of shares for warrants outstanding. 1.3MM shares issued in exchange for removing the reserve of 8.4MM shares that couldve been issued by the warrants. Brings the total available shares that could be issued up to 22.4MM.
Also there was a restriction under the warrant agreement that MNKD could only tap the ATM for $10MM. They can now use the full $50MM available.
My opinion here is that it doesnt sound like they want to go this way, but have now put another tool in their belt for leverage.
|
|
|
Post by dreamboatcruise on Oct 2, 2017 10:55:42 GMT -5
peppy... thanks, but I still don't understand what that means. Did Mike say that this provides some amount of additional funding?
|
|
|
Post by peppy on Oct 2, 2017 10:58:14 GMT -5
peppy ... thanks, but I still don't understand what that means. Did Mike say that this provides some amount of additional funding? real just spelled it out for all of us.
Thank you real. ! ! !
|
|
|
Post by patten1962 on Oct 2, 2017 11:25:07 GMT -5
I missed the call. What was said? hello patten. you can listen to the call later. what was said. table four allows Mannkind to differentiate afrezza from other insulins. money has been raised.
www.screencast.com/t/PRuoaiIP look at the table. subq rapid acting insulin last 5 hours.... the tail.
with afrezza, it seems less death becomes us.
New contract with large insurer expected 2018.
Listening now.
|
|
|
Post by sr71 on Oct 2, 2017 12:08:29 GMT -5
There was no money raised. There was an exchange of shares for warrants outstanding. 1.3MM shares issued in exchange for removing the reserve of 8.4MM shares that couldve been issued by the warrants. Brings the total available shares that could be issued up to 22.4MM.
Also there was a restriction under the warrant agreement that MNKD could only tap the ATM for $10MM. They can now use the full $50MM available.
My opinion here is that it doesnt sound like they want to go this way, but have now put another tool in their belt for leverage.
22.4 million available shares possibly could be issued at approximately $2 to generate $45 million in new funds for MNKD. With the ATM limit up to $50 million (is $10 million already drawn?), this would make another $40 million available.
Together, that is $85 million to draw upon if needed. That should lengthen the runway considerably from what it was prior to today.
|
|